Biopharmaceutical Market

Table Of Content

1. Executive Summary

1.1.Regional Market Share

1.2. Business Trends

1.3. Biopharmaceutical Market: COVID-19 Outbreak

1.4.Regional Trends

1.5. Segmentation Snapshot

2. Research Methodology

2.1. Research Objective

2.2.Research Approach

2.3.Data Sourcing and Methodology 

2.4. Primary Research

2.5. Secondary Research

2.5.1.Paid Sources

2.5.2. Public Sources

2.6.Market Size Estimation and Data Triangulation

3. Market Characteristics

3.1. Market Definition

3.2.Biopharmaceutical Market: COVID-19 Impact

3.3.Key Segmentations 

3.4. Key Developments

3.5. Allied Industry Data

4. Biopharmaceutical Market – Industry Insights

4.1.Industry Segmentation

4.2. COVID-19 overview on world economy

4.3. Industry ecosystem Channel analysis

4.4. Innovation & Sustainability

5. Macroeconomic Indicators

6. Recent Developments

7.Market Dynamics

7.1. Introduction

7.2.Growth Drivers

7.3.Market Opportunities

7.4. Market Restraints

7.5.Market Trends

8. Risk Analysis

9. Market Analysis

9.1. Porters Five Forces

9.2.PEST Analysis

9.2.1. Political 

9.2.2.Economic

9.2.3.Social

9.2.4.Technological

10. Biopharmaceutical Market

10.1.Overview

10.2. Historical Analysis (2016-2021)

10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast

11.Biopharmaceutical Market Size & Forecast 2022A-2032F

11.1.Overview

11.2. Key Findings

11.3. Market Segmentation

11.3.1.By Product Type

11.3.1.1. Purified Proteins

11.3.1.1.1. By Value (USD Million) 2022-2032F

11.3.1.1.2.Market Share (%) 2022-2032F

11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F

11.3.1.2.Recombinant Growth Factors

11.3.1.2.1.By Value (USD Million) 2022-2032F

11.3.1.2.2. Market Share (%) 2022-2032F

11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F

11.3.1.3.Recombinant Proteins

11.3.1.3.1.By Value (USD Million) 2022-2032F

11.3.1.3.2. Market Share (%) 2022-2032F

11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F

11.3.1.4.Recombinant Hormone

11.3.1.4.1.By Value (USD Million) 2022-2032F

11.3.1.4.2. Market Share (%) 2022-2032F

11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F

11.3.1.5.Synthetic Immunomodulatory

11.3.1.5.1.By Value (USD Million) 2022-2032F

11.3.1.5.2. Market Share (%) 2022-2032F

11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F

11.3.1.6.Monoclonal Antibodies

11.3.1.6.1.By Value (USD Million) 2022-2032F

11.3.1.6.2. Market Share (%) 2022-2032F

11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F

11.3.1.7.Vaccines

11.3.1.7.1.By Value (USD Million) 2022-2032F

11.3.1.7.2. Market Share (%) 2022-2032F

11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F

11.3.1.8.Other

11.3.1.8.1.By Value (USD Million) 2022-2032F

11.3.1.8.2. Market Share (%) 2022-2032F

11.3.1.8.3. Y-o-Y Growth (%) 2022-2032F

11.3.2. By Service

11.3.2.1.Custom Testing / Customer Proprietary Testing

11.3.2.1.1.By Value (USD Million) 2022-2032F

11.3.2.1.2. Market Share (%) 2022-2032F

11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F

11.3.2.2. Laboratory Testing

11.3.2.2.1. By Value (USD Million) 2022-2032F

11.3.2.2.2.Market Share (%) 2022-2032F

11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F

11.3.2.3. Compendial, and Multi Compendial Laboratory Testing

11.3.2.3.1. By Value (USD Million) 2022-2032F

11.3.2.3.2.Market Share (%) 2022-2032F

11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F

11.3.3. By Raw Material Type

11.3.3.1.Active Pharmaceutical Ingredients (API)

11.3.3.1.1.By Value (USD Million) 2022-2032F

11.3.3.1.2. Market Share (%) 2022-2032F

11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F

11.3.3.2. Formulation Excipients

11.3.3.2.1. By Value (USD Million) 2022-2032F

11.3.3.2.2.Market Share (%) 2022-2032F

11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F

11.3.3.3. Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support

11.3.3.3.1. By Value (USD Million) 2022-2032F

11.3.3.3.2.Market Share (%) 2022-2032F

11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F

11.3.4. By Application

11.3.4.1.Autoimmune Disorders

11.3.4.1.1.By Value (USD Million) 2022-2032F

11.3.4.1.2. Market Share (%) 2022-2032F

11.3.4.1.3. Y-o-Y Growth (%) 2022-2032F

11.3.4.2. Metabolic Disorders

11.3.4.2.1. By Value (USD Million) 2022-2032F

11.3.4.2.2.Market Share (%) 2022-2032F

11.3.4.2.3. Y-o-Y Growth (%) 2022-2032F

11.3.4.3. Oncology

11.3.4.3.1. By Value (USD Million) 2022-2032F

11.3.4.3.2. Market Share (%) 2022-2032F

11.3.4.3.3. Y-o-Y Growth (%) 2022-2032F

11.3.4.4. Inflammatory and Infectious Diseases

11.3.4.4.1.By Value (USD Million) 2022-2032F

11.3.4.4.2. Market Share (%) 2022-2032F

11.3.4.4.3. Y-o-Y Growth (%) 2022-2032F

11.3.4.5. Hormonal Disorders

11.3.4.5.1.By Value (USD Million) 2022-2032F

11.3.4.5.2. Market Share (%) 2022-2032F

11.3.4.5.3. Y-o-Y Growth (%) 2022-2032F

11.3.4.6. Neurological Diseases

11.3.4.6.1. By Value (USD Million) 2022-2032F

11.3.4.6.2.Market Share (%) 2022-2032F

11.3.4.6.3.Y-o-Y Growth (%) 2022-2032F

11.3.4.7. Cardiovascular Diseases

11.3.4.7.1. By Value (USD Million) 2022-2032F

11.3.4.7.2.Market Share (%) 2022-2032F

11.3.4.7.3.Y-o-Y Growth (%) 2022-2032F

11.3.4.8. Other

11.3.4.8.1.By Value (USD Million) 2022-2032F

11.3.4.8.2. Market Share (%) 2022-2032F

11.3.4.8.3. Y-o-Y Growth (%) 2022-2032F

12. North America Biopharmaceutical Market Size & Forecast 2022A-2032F

12.1. Overview

12.2. Key Findings

12.3. Market Segmentation

12.3.1. By Product Type

12.3.2.By Service

12.3.3.By Raw Material Type

12.3.4.By Application

12.4. Country

12.4.1.United States

12.4.2. Canada

13. Europe Biopharmaceutical Market Size & Forecast 2022A-2032F

13.1. Overview

13.2. Key Findings

13.3. Market Segmentation

13.3.1. By Product Type

13.3.2.By Service

13.3.3.By Raw Material Type

13.3.4.By Application

13.4. Country

13.4.1.Germany

13.4.2. United Kingdom

13.4.3. France

13.4.4. Italy

13.4.5. Spain

13.4.6. Russia

13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)

14. Asia Biopharmaceutical Market Size & Forecast 2022A-2032F

14.1.Overview

14.2. Key Findings

14.3. Market Segmentation

14.3.1. By Product Type

14.3.2.By Service

14.3.3.By Raw Material Type

14.3.4. By Application

14.4. Country

14.4.1.India

14.4.2. China

14.4.3. South Korea

14.4.4. Japan

14.4.5. Rest of APAC

15. Middle East and Africa Biopharmaceutical Market Size & Forecast 2022A-2032F

15.1.Overview

15.2. Key Findings

15.3. Market Segmentation

15.3.1. By Product Type

15.3.2.By Service

15.3.3.By Raw Material Type

15.3.4.By Application

15.4. Country

15.4.1.Israel

15.4.2. GCC

15.4.3. North Africa

15.4.4. South Africa

15.4.5. Rest of Middle East and Africa

16. Latin America Biopharmaceutical Market Size & Forecast 2022A-2032F

16.1. Overview

16.2. Key Findings

16.3. Market Segmentation

16.3.1. By Product Type

16.3.2.By Service

16.3.3.By Raw Material Type

16.3.4.By Application

16.4. Country

16.4.1. Mexico

16.4.2. Brazil

16.4.3. Rest of Latin America

17. Competitive Landscape

17.1. Company market share, 2021

17.2.Key player overview

17.3. Key stakeholders

18. Company Profiles 

18.1.Amgen Inc.

18.1.1.Company Overview

18.1.2.Financial Overview

18.1.3.Key Product; Analysis

18.1.4.Company Assessment

18.1.4.1.Product Portfolio

18.1.4.2. Key Clients

18.1.4.3. Market Share 

18.1.4.4. Recent News & Development (Last 3 Yrs.)

18.1.4.5. Executive Team

18.2. AstraZeneca

18.3. Johnson & Johnson Private Limited

18.4.Lilly

18.5. Pfizer Inc.

18.6. Sanofi

18.7. Abbott

18.8.Novartis AG

18.9. F. Hoffmann-La Roche Ltd.

18.10.Novo Nordisk A/S

18.11.bioMérieux

18.12.Merck & Co., Inc.

18.13.Bristol-Myers Squibb Company

18.14.GlaxoSmithKline Plc

18.15.Bayer AG

18.16. Biogen

18.17. Other Prominent Players

19. Appendix

20.Consultant Recommendation